Pharmacokinetic–pharmacodynamic modelling for the determination of optimal dosing regimen of florfenicol in Nile tilapia (Oreochromis niloticus) at different water temperatures and antimicrobial susceptibility levels
Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a pharmacokinetic–pharmacodynamic (PK‐PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the tempera...
Saved in:
Published in | Journal of fish diseases Vol. 42; no. 8; pp. 1181 - 1190 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a pharmacokinetic–pharmacodynamic (PK‐PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature‐dependent PK and the pathogen‐dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg−1 day−1 (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed Cmin(ss) while at 28 and 32°C underestimation of the Cmin(ss) in a dose‐dependent manner was observed and likely due to the occurrence of non‐linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK‐PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non‐linearity of FF in tilapia warrant further study. |
---|---|
AbstractList | Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a pharmacokinetic–pharmacodynamic (PK‐PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature‐dependent PK and the pathogen‐dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg−1 day−1 (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed Cmin(ss) while at 28 and 32°C underestimation of the Cmin(ss) in a dose‐dependent manner was observed and likely due to the occurrence of non‐linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK‐PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non‐linearity of FF in tilapia warrant further study. Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a pharmacokinetic–pharmacodynamic (PK‐PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature‐dependent PK and the pathogen‐dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg −1 day −1 (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed C min(ss) while at 28 and 32°C underestimation of the C min(ss) in a dose‐dependent manner was observed and likely due to the occurrence of non‐linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK‐PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non‐linearity of FF in tilapia warrant further study. Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a pharmacokinetic–pharmacodynamic (PK‐PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature‐dependent PK and the pathogen‐dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg−1 day−1 (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed Cmin(ss) while at 28 and 32°C underestimation of the Cmin(ss) in a dose‐dependent manner was observed and likely due to the occurrence of non‐linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK‐PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non‐linearity of FF in tilapia warrant further study. Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug-related side effects. The current study established a pharmacokinetic-pharmacodynamic (PK-PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature-dependent PK and the pathogen-dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg-1 day-1 (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed Cmin(ss) while at 28 and 32°C underestimation of the Cmin(ss) in a dose-dependent manner was observed and likely due to the occurrence of non-linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK-PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non-linearity of FF in tilapia warrant further study.Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug-related side effects. The current study established a pharmacokinetic-pharmacodynamic (PK-PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature-dependent PK and the pathogen-dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg-1 day-1 (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed Cmin(ss) while at 28 and 32°C underestimation of the Cmin(ss) in a dose-dependent manner was observed and likely due to the occurrence of non-linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK-PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non-linearity of FF in tilapia warrant further study. Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug-related side effects. The current study established a pharmacokinetic-pharmacodynamic (PK-PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature-dependent PK and the pathogen-dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg day (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed C while at 28 and 32°C underestimation of the C in a dose-dependent manner was observed and likely due to the occurrence of non-linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK-PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non-linearity of FF in tilapia warrant further study. Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a pharmacokinetic–pharmacodynamic (PK‐PD) model for the determination of optimal antibacterial dosing regimen in fish taken into consideration the temperature‐dependent PK and the pathogen‐dependent antimicrobial susceptibility, using florfenicol (FF) in Nile tilapia as an example. The calculated optimal dosages significantly varied by temperature and target MIC levels, ranging from 2.23 (MIC 1 µg/ml at 24°C) to 34.88 mg kg⁻¹ day⁻¹ (MIC 4 µg/ml at 32°C). The appropriateness of the calculated dosages was successfully verified by the in vivo studies. After 5 days of oral administration of the calculated optimal dosage at 24°C, the predicted plasma drug values were in line with the mean observed Cₘᵢₙ₍ₛₛ₎ while at 28 and 32°C underestimation of the Cₘᵢₙ₍ₛₛ₎ in a dose‐dependent manner was observed and likely due to the occurrence of non‐linear PK at high dosages. The averaged serum protein binding of FF was 19.1%. Our results demonstrated the appropriateness and clinical applicability of the developed PK‐PD approach for the determination of optimal dosing regimens at given temperatures and MICs. Saturation metabolism and PK non‐linearity of FF in tilapia warrant further study. |
Author | Rairat, Tirawat Hsieh, Chia‐Yu Thongpiam, Wipavee Chou, Chi‐Chung |
Author_xml | – sequence: 1 givenname: Tirawat surname: Rairat fullname: Rairat, Tirawat organization: National Chung Hsing University – sequence: 2 givenname: Chia‐Yu surname: Hsieh fullname: Hsieh, Chia‐Yu organization: National Chung Hsing University – sequence: 3 givenname: Wipavee surname: Thongpiam fullname: Thongpiam, Wipavee organization: National Chung Hsing University – sequence: 4 givenname: Chi‐Chung orcidid: 0000-0002-4622-2552 surname: Chou fullname: Chou, Chi‐Chung email: ccchou@nchu.edu.tw organization: National Chung Hsing University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31157416$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1uFSEUx4mpsbfVhS9gSNy0i9vCMAx3lqZaP9JYF7qeAHPo5crACIzN3fkOfbsufRK5H900GkkICfzO_5zD_xyhAx88IPSSkjNa1vnK9GeUkZo8QTPKGj6vREMP0IzQmsyFEPwQHaW0IoQKTptn6JBRykVNmxm6_7KUcZA6fLcestW_f92N-5t-7eVgNR5CD85Zf4NNiDgvAfeQIQ7Wy2yDx8HgMGY7SIf7kDZchBs7wPbFuBANeKuDw9bjz9YBztbJ0Up8ch0h6GUMg03YWxdK_imdYplxb42BCD7jW1ly4QzDCFHmKULC0vdll4xWx6BsyZumpKHUoKyzeY0d_ASXnqOnRroEL_bnMfp2-e7rxYf51fX7jxdvruaaLRoybynndWU0qxRZKMmE6fuqaVmthDJatIRKtaiMNEaBNopIVpue14Zw2WqpCDtGJzvdMYYfE6TclX50-TLpIUypq1gl2lZUbfN_tGJ1vahLPQV9_QhdhSn60kihOG8XvBEbwVd7alID9N0Yiw9x3T0YXIDzHVC-KqUIptM2b33LUVrXUdJtRqgrI9RtR6hEnD6KeBD9G7tXvy2-rv8Ndp8u3-4i_gDsvNzk |
CitedBy_id | crossref_primary_10_1016_j_aquaculture_2022_738719 crossref_primary_10_1080_19440049_2022_2155710 crossref_primary_10_1111_jvp_13485 crossref_primary_10_1016_j_heliyon_2020_e05716 crossref_primary_10_3389_fvets_2021_755585 crossref_primary_10_1638_2020_0130 crossref_primary_10_3390_ani11061521 crossref_primary_10_1016_j_aquaculture_2019_734794 crossref_primary_10_1016_j_tig_2021_07_002 crossref_primary_10_1111_jfd_13719 crossref_primary_10_1016_j_aquaculture_2021_737372 crossref_primary_10_1016_j_aquaculture_2023_740222 crossref_primary_10_1016_j_aquaculture_2019_734900 crossref_primary_10_1016_j_aquaculture_2023_739978 crossref_primary_10_1016_j_jchromb_2024_124282 crossref_primary_10_1111_jvp_12978 crossref_primary_10_1016_j_fsi_2022_02_034 crossref_primary_10_1080_01652176_2024_2396573 crossref_primary_10_1111_jfd_13480 crossref_primary_10_3389_fvets_2021_679657 crossref_primary_10_1111_jvp_13405 crossref_primary_10_1016_j_etap_2024_104471 crossref_primary_10_1111_jvp_13115 |
Cites_doi | 10.1016/j.jiac.2015.02.001 10.1177/104063870301500612 10.1002/9781118675014.ch39 10.1016/S0195-5616(88)50035-9 10.1111/j.1365-2885.2004.00603.x 10.1111/jvp.12678 10.1016/j.vetmic.2011.07.030 10.1016/0044-8486(95)01225-7 10.1002/9781118786758 10.1111/j.1461-0248.2009.01415.x 10.1002/9781119152125.ch10 10.1111/jfd.12525 10.1046/j.1439-0442.2001.00339.x 10.1016/j.aquaculture.2018.12.081 10.1016/S0034-5288(02)00039-5 10.1023/A:1024406221962 10.1007/BF00588387 10.1111/j.1365-2885.1994.tb00241.x 10.1533/9780857095732.2.161 10.1016/j.aquaculture.2008.08.014 10.1111/jfd.12549 10.3109/00498254.2015.1089453 10.1111/are.12764 10.1111/j.1365-2885.1987.tb00534.x 10.1016/j.aquaculture.2010.07.003 10.1016/0044-8486(93)90153-P 10.1577/1548-8667(1996)008<0292:POFAIM>2.3.CO;2 10.1016/S0924-8579(00)00142-4 10.1080/00071669708418013 10.1111/j.1365-2885.2004.00613.x 10.1186/1746-6148-9-126 10.1086/314059 10.1111/j.1365-2885.2009.01155.x 10.1016/j.idc.2004.04.012 10.1111/j.1365-2761.1987.tb01057.x 10.1016/j.aquaculture.2018.08.023 10.1016/j.aquaculture.2018.04.037 10.1046/j.1365-2656.1999.00337.x 10.1089/mdr.2008.0848 |
ContentType | Journal Article |
Copyright | 2019 John Wiley & Sons Ltd 2019 John Wiley & Sons Ltd. Copyright © 2019 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2019 John Wiley & Sons Ltd – notice: 2019 John Wiley & Sons Ltd. – notice: Copyright © 2019 John Wiley & Sons Ltd |
DBID | AAYXX CITATION NPM 7QL 7TN 7U9 8FD C1K F1W FR3 H94 H95 H98 H99 L.F L.G M7N P64 7X8 7S9 L.6 |
DOI | 10.1111/jfd.13040 |
DatabaseName | CrossRef PubMed Bacteriology Abstracts (Microbiology B) Oceanic Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management ASFA: Aquatic Sciences and Fisheries Abstracts Engineering Research Database AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) Aquaculture Abstracts ASFA: Marine Biotechnology Abstracts Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts Aquatic Science & Fisheries Abstracts (ASFA) Professional Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef PubMed Aquatic Science & Fisheries Abstracts (ASFA) Professional Virology and AIDS Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Aquatic Science & Fisheries Abstracts (ASFA) Aquaculture Abstracts Oceanic Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) ASFA: Aquatic Sciences and Fisheries Abstracts Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts AIDS and Cancer Research Abstracts Engineering Research Database Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | CrossRef Aquatic Science & Fisheries Abstracts (ASFA) Professional MEDLINE - Academic PubMed AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Agriculture |
EISSN | 1365-2761 |
EndPage | 1190 |
ExternalDocumentID | 31157416 10_1111_jfd_13040 JFD13040 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHBH AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BGJEQ BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CAG COF CS3 D-E D-F D-I DC6 DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBS ECGQY EJD ESX F00 F01 F04 F5P FEDTE FZ0 G-S G.N GODZA H.T H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG P2P P2W P2X P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ UB1 UPT VH1 W8V W99 WBKPD WH7 WIH WIK WOHZO WQJ WRC WUPDE WXSBR WYISQ XG1 YQT ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7QL 7TN 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K F1W FR3 H94 H95 H98 H99 L.F L.G M7N P64 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c3860-915542fc32b08ba37fdd26934b7bfc7901ab82faffbecfb0a34fd54f05a9cab03 |
IEDL.DBID | DR2 |
ISSN | 0140-7775 1365-2761 |
IngestDate | Fri Jul 11 18:27:47 EDT 2025 Fri Jul 11 07:36:08 EDT 2025 Fri Jul 25 19:36:57 EDT 2025 Wed Feb 19 02:35:32 EST 2025 Tue Jul 01 00:58:03 EDT 2025 Thu Apr 24 22:51:35 EDT 2025 Wed Jan 22 16:41:10 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | pharmacokinetic-pharmacodynamic Nile tilapia florfenicol optimal dosing regimen |
Language | English |
License | 2019 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3860-915542fc32b08ba37fdd26934b7bfc7901ab82faffbecfb0a34fd54f05a9cab03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4622-2552 |
PMID | 31157416 |
PQID | 2255985676 |
PQPubID | 37796 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2327997296 proquest_miscellaneous_2234484542 proquest_journals_2255985676 pubmed_primary_31157416 crossref_citationtrail_10_1111_jfd_13040 crossref_primary_10_1111_jfd_13040 wiley_primary_10_1111_jfd_13040_JFD13040 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2019 |
PublicationDateYYYYMMDD | 2019-08-01 |
PublicationDate_xml | – month: 08 year: 2019 text: August 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of fish diseases |
PublicationTitleAlternate | J Fish Dis |
PublicationYear | 2019 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2017; 40 2010; 307 2010; 13 2004; 27 2004; 7 2003; 15 2001; 48 2018; 41 1996; 143 2013; 9 2018; 493 2000; 14 2008; 29 1996; 8 2016; 47 2016; 46 2010; 33 1987; 10 2012 1988; 18 2011 2010 2002; 73 1988; 54 1999; 68 2008; 14 1997; 28 2005 2004 2002 2019; 503 2008; 285 2015; 7 1999 2012; 154 2004; 18 2015; 21 2000; 31 2019 2019; 498 2003; 26 2018 1997; 38 2017 2016 2013 1994; 17 2003; 20 1993; 112 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 U.S. FDA (e_1_2_7_53_1) 2018 Wall A. E. (e_1_2_7_55_1) 2005 e_1_2_7_13_1 Thai FDA (e_1_2_7_50_1) 2012 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 EMA (e_1_2_7_15_1) 2011 e_1_2_7_28_1 Riviere J. E. (e_1_2_7_43_1) 2003; 26 Popma T. (e_1_2_7_38_1) 1999 Taiwan Council of Agriculture (e_1_2_7_49_1) 2019 Wang Q. (e_1_2_7_56_1) 2008; 29 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_37_1 Intervet (e_1_2_7_22_1) 2013 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_4_1 Leary S. (e_1_2_7_25_1) 2016 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_12_1 Oshima Y. (e_1_2_7_36_1) 2004; 7 e_1_2_7_44_1 Lin M. (e_1_2_7_29_1) 2015; 7 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 Riviere J. E. (e_1_2_7_42_1) 1997; 28 EMEA (e_1_2_7_17_1) 2002 e_1_2_7_51_1 e_1_2_7_30_1 EMA (e_1_2_7_16_1) 2016 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 Ritschel W. A. (e_1_2_7_41_1) 2004 Jambhekar S. S. (e_1_2_7_23_1) 2012 |
References_xml | – year: 2011 – volume: 47 start-page: 3136 year: 2016 end-page: 3144 article-title: Antimicrobial susceptibility and enrofloxacin resistance of streptococcal bacteria from farmed Nile tilapia, (Linnaeus 1758) in Thailand publication-title: Aquaculture Research – volume: 28 start-page: 3 year: 1997 end-page: 19 article-title: Basic principles and techniques of pharmacokinetic modeling publication-title: Journal of Zoo and Wildlife Medicine – volume: 285 start-page: 255 year: 2008 end-page: 259 article-title: Patterns of resistance to florfenicol and bicyclomycin in Brazilian strains of motile aeromonads publication-title: Aquaculture – volume: 307 start-page: 71 year: 2010 end-page: 74 article-title: Plasma and tissue depletion of florfenicol in olive flounder ( ) after oral administration publication-title: Aquaculture – volume: 18 start-page: 331 year: 1988 end-page: 348 article-title: Fish chemotherapeutics publication-title: Veterinary Clinics of North America: Small Animal Practice – volume: 7 start-page: 61 issue: 2 year: 2004 end-page: 68 article-title: Relationship between temperature and pharmacokinetic parameters of florfenicol in carp ( ) publication-title: Japanese Journal of Environmental Toxicology – start-page: 645 year: 2013 end-page: 661 – start-page: 263 year: 2017 end-page: 278 – volume: 503 start-page: 483 year: 2019 end-page: 488 article-title: Temperature‐dependent pharmacokinetics of florfenicol in Nile tilapia ( ) following single oral and intravenous administration publication-title: Aquaculture – volume: 31 start-page: S40 year: 2000 end-page: S44 article-title: Clinical pharmacology of the fluoroquinolones: Studies in human dynamic/kinetic models publication-title: Clinical Infectious Diseases – volume: 40 start-page: 411 year: 2017 end-page: 424 article-title: Pharmacokinetic model of florfenicol in turbot ( ): Establishment of optimal dosage and administration in medicated feed publication-title: Journal of Fish Diseases – volume: 46 start-page: 522 year: 2016 end-page: 529 article-title: Pharmacokinetics, pharmacokinetic‐pharmacodynamic relationship, and withdrawal period of amoxicillin sodium in olive flounder ( ) publication-title: Xenobiotica – year: 2018 – volume: 26 start-page: 1181 issue: Suppl 2 year: 2003 end-page: 271 article-title: USP veterinary pharmaceutical information monographs: Antibiotics publication-title: Journal of Veterinary Pharmacology and Therapeutics – volume: 20 start-page: 1015 issue: 7 year: 2003 end-page: 1021 article-title: Modulation of nonspecific binding in ultrafiltration protein binding studies publication-title: Pharmaceutical Research – volume: 27 start-page: 503 year: 2004 end-page: 514 article-title: Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine publication-title: Journal of Veterinary Pharmacology and Therapeutics – volume: 27 start-page: 467 year: 2004 end-page: 477 article-title: Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine publication-title: Journal of Veterinary Pharmacology and Therapeutics – start-page: 213 year: 2004 end-page: 215 – volume: 9 start-page: 126 year: 2013 article-title: Integrated pharmacokinetics/pharmacodynamics parameters‐based dosing guidelines of enrofloxacin in grass carp to minimize selection of drug resistance publication-title: BMC Veterinary Research – volume: 14 start-page: 311 year: 2008 end-page: 316 article-title: Antimicrobial susceptibility pattern of isolates from natural outbreaks of bacillary necrosis of in Vietnam publication-title: Microbial Drug Resistance – volume: 21 start-page: 319 year: 2015 end-page: 329 article-title: Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents publication-title: Journal of Infection and Chemotherapy – volume: 8 start-page: 292 year: 1996 end-page: 301 article-title: Pharmacokinetics of florfenicol and its metabolite florfenicol amine in Atlantic salmon publication-title: Journal of Aquatic Animal Health – year: 2019 – start-page: 161 year: 2012 end-page: 189 – volume: 48 start-page: 129 year: 2001 end-page: 136 article-title: Disposition kinetics of florfenicol in goats by using two analytical methods publication-title: Journal of Veterinary Medicine Series A – volume: 18 start-page: 451 year: 2004 end-page: 465 article-title: Pharmacodynamics of antimicrobial drugs publication-title: Infectious Disease Clinics of North America – volume: 7 start-page: 126 year: 2015 end-page: 130 article-title: Comparative pharmacokinetics of florfenicol in Japanese eels at different temperature publication-title: Animal Husbandry and Feed Science – volume: 154 start-page: 407 year: 2012 end-page: 412 article-title: Genetic analysis and antimicrobial susceptibility of subsp. (syn. ) isolates from fish publication-title: Veterinary Microbiology – volume: 13 start-page: 184 year: 2010 end-page: 193 article-title: The intraspecific scaling of metabolic rate with body mass in fishes depends on lifestyle and temperature publication-title: Ecology Letters – start-page: 73 year: 2005 end-page: 85 – volume: 17 start-page: 253 year: 1994 end-page: 258 article-title: Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle publication-title: Journal of Veterinary Pharmacology and Therapeutics – volume: 73 start-page: 105 year: 2002 end-page: 114 article-title: The pharmacokinetic‐pharmacodynamic approach to a rational dosage regimen for antibiotics publication-title: Research in Veterinary Science – year: 2016 – year: 2010 – year: 2012 – volume: 14 start-page: 307 year: 2000 end-page: 313 article-title: Antibiotic treatment for animals: Effect on bacterial population and dosage regimen optimisation publication-title: International Journal of Antimicrobial Agents – start-page: 261 year: 2012 – volume: 38 start-page: 425 year: 1997 end-page: 428 article-title: Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens publication-title: British Poultry Science – volume: 112 start-page: 1181 year: 1993 end-page: 11 article-title: Single dose pharmacokinetic study of florfenicol in Atlantic salmon ( ) in seawater at 11°C publication-title: Aquaculture – year: 2002 – volume: 29 start-page: 19 year: 2008 end-page: 26 article-title: Residue elimination of florfenicol, oxytetracycline and sulfamonomethoxine in following oral administration publication-title: Marine Fisheries Research – volume: 41 start-page: 887 year: 2018 end-page: 893 article-title: Pharmacokinetic/pharmacodynamic relationship of enrofloxacin against in crucian carp ( ) publication-title: Journal of Veterinary Pharmacology and Therapeutics – volume: 10 start-page: 153 year: 1987 end-page: 163 article-title: Pharmacokinetics and tissue distribution of oxytetracycline in carp, L., following different routes of administration publication-title: Journal of Fish Diseases – volume: 33 start-page: 471 year: 2010 end-page: 479 article-title: Pharmacokinetics and tissue depletion of florfenicol in Leghorn and Taiwan Native chickens publication-title: Journal of Veterinary Pharmacology and Therapeutics – volume: 143 start-page: 33 year: 1996 end-page: 42 article-title: Pharmacokinetic study of oxytetracycline in healthy and vibriosis‐infected ayu ( ) publication-title: Aquaculture – volume: 10 start-page: 233 year: 1987 end-page: 240 article-title: Florfenicol in non‐lactating dairy cows: Pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils publication-title: Journal of Veterinary Pharmacology and Therapeutics – volume: 40 start-page: 679 year: 2017 end-page: 686 article-title: Provisional epidemiological cutoff values for standard broth microdilution susceptibility testing of publication-title: Journal of Fish Diseases – volume: 54 start-page: 509 issue: 6 year: 1988 end-page: 520 article-title: Columnaris infection among cultured Nile tilapia publication-title: Antonie Van Leeuwenhoek – volume: 68 start-page: 893 year: 1999 end-page: 905 article-title: Scaling of metabolic rate with body mass and temperature in teleost fish publication-title: Journal of Animal Ecology – volume: 493 start-page: 51 year: 2018 end-page: 60 article-title: Recurrent infection in Nile tilapia ( ) treated with florfenicol publication-title: Aquaculture – volume: 15 start-page: 576 year: 2003 end-page: 579 article-title: evaluation of the susceptibility of , etiological agent of enteric septicemia in channel catfish, (Rafinesque), to florfenicol publication-title: Journal of Veterinary Diagnostic Investigation – volume: 498 start-page: 100 year: 2019 end-page: 108 article-title: Seasonal dynamics of bacterial pathogens of Nile tilapia farmed in a Brazilian reservoir publication-title: Aquaculture – year: 2013 – year: 1999 – ident: e_1_2_7_5_1 doi: 10.1016/j.jiac.2015.02.001 – ident: e_1_2_7_33_1 doi: 10.1177/104063870301500612 – ident: e_1_2_7_40_1 doi: 10.1002/9781118675014.ch39 – volume-title: Guideline for the demonstration of efficacy for veterinary medicinal products containing antimicrobial substances, EMA/CVMP/627/2001‐Rev.1 year: 2016 ident: e_1_2_7_16_1 – ident: e_1_2_7_48_1 doi: 10.1016/S0195-5616(88)50035-9 – ident: e_1_2_7_34_1 doi: 10.1111/j.1365-2885.2004.00603.x – ident: e_1_2_7_45_1 doi: 10.1111/jvp.12678 – ident: e_1_2_7_47_1 doi: 10.1016/j.vetmic.2011.07.030 – ident: e_1_2_7_54_1 doi: 10.1016/0044-8486(95)01225-7 – volume: 28 start-page: 3 year: 1997 ident: e_1_2_7_42_1 article-title: Basic principles and techniques of pharmacokinetic modeling publication-title: Journal of Zoo and Wildlife Medicine – ident: e_1_2_7_35_1 doi: 10.1002/9781118786758 – ident: e_1_2_7_24_1 doi: 10.1111/j.1461-0248.2009.01415.x – volume-title: Tilapia: Life history and biology year: 1999 ident: e_1_2_7_38_1 – start-page: 73 volume-title: The veterinary formulary year: 2005 ident: e_1_2_7_55_1 – ident: e_1_2_7_7_1 doi: 10.1002/9781119152125.ch10 – ident: e_1_2_7_11_1 doi: 10.1111/jfd.12525 – ident: e_1_2_7_6_1 doi: 10.1046/j.1439-0442.2001.00339.x – volume-title: Guidelines for the use of animal drugs article 3 annex I: Code of practice for aquatic animal drugs. Council of Agriculture (Executive Yuan), Taiwan year: 2019 ident: e_1_2_7_49_1 – volume-title: Restrictions on antimicrobial use in aquaculture (Ministry of Public Health 1010/4/1762, 20 Feb 2012) year: 2012 ident: e_1_2_7_50_1 – volume-title: Environmental assessment for AQUAFLOR (Florfenicol) 50% type A medicated article fed at a dose up to 15 mg florfenicol/kg body weight/day for control of mortality associated with bacterial Diseases in freshwater‐reared finfish in recirculating aquaculture systems year: 2013 ident: e_1_2_7_22_1 – ident: e_1_2_7_39_1 doi: 10.1016/j.aquaculture.2018.12.081 – ident: e_1_2_7_51_1 doi: 10.1016/S0034-5288(02)00039-5 – ident: e_1_2_7_26_1 doi: 10.1023/A:1024406221962 – ident: e_1_2_7_4_1 doi: 10.1007/BF00588387 – volume: 29 start-page: 19 year: 2008 ident: e_1_2_7_56_1 article-title: Residue elimination of florfenicol, oxytetracycline and sulfamonomethoxine in Scophthalmus maximus following oral administration publication-title: Marine Fisheries Research – volume-title: Guideline on demonstration of target animal safety and efficacy of veterinary medicinal products intended for use in farmed finfish, EMA/CVMP/EWP/459868/2008 year: 2011 ident: e_1_2_7_15_1 – ident: e_1_2_7_30_1 doi: 10.1111/j.1365-2885.1994.tb00241.x – ident: e_1_2_7_46_1 doi: 10.1533/9780857095732.2.161 – ident: e_1_2_7_19_1 doi: 10.1016/j.aquaculture.2008.08.014 – ident: e_1_2_7_18_1 doi: 10.1111/jfd.12549 – ident: e_1_2_7_37_1 doi: 10.3109/00498254.2015.1089453 – ident: e_1_2_7_31_1 doi: 10.1111/are.12764 – ident: e_1_2_7_8_1 doi: 10.1111/j.1365-2885.1987.tb00534.x – ident: e_1_2_7_28_1 doi: 10.1016/j.aquaculture.2010.07.003 – volume-title: Approved aquaculture drugs year: 2018 ident: e_1_2_7_53_1 – ident: e_1_2_7_32_1 doi: 10.1016/0044-8486(93)90153-P – start-page: 213 volume-title: Handbook of basic pharmacokinetics… Including clinical applications year: 2004 ident: e_1_2_7_41_1 – ident: e_1_2_7_21_1 doi: 10.1577/1548-8667(1996)008<0292:POFAIM>2.3.CO;2 – volume: 26 start-page: 1181 issue: 2 year: 2003 ident: e_1_2_7_43_1 article-title: USP veterinary pharmaceutical information monographs: Antibiotics publication-title: Journal of Veterinary Pharmacology and Therapeutics – ident: e_1_2_7_3_1 doi: 10.1016/S0924-8579(00)00142-4 – volume: 7 start-page: 61 issue: 2 year: 2004 ident: e_1_2_7_36_1 article-title: Relationship between temperature and pharmacokinetic parameters of florfenicol in carp (Cyprinus carpio) publication-title: Japanese Journal of Environmental Toxicology – ident: e_1_2_7_2_1 doi: 10.1080/00071669708418013 – ident: e_1_2_7_52_1 doi: 10.1111/j.1365-2885.2004.00613.x – volume-title: Florfenicol (Extension to All Food Producing Species), Summary Report (6), EMEA/MRL/822/02‐FINAL year: 2002 ident: e_1_2_7_17_1 – ident: e_1_2_7_57_1 doi: 10.1186/1746-6148-9-126 – ident: e_1_2_7_44_1 doi: 10.1086/314059 – ident: e_1_2_7_9_1 doi: 10.1111/j.1365-2885.2009.01155.x – ident: e_1_2_7_27_1 doi: 10.1016/j.idc.2004.04.012 – start-page: 261 volume-title: Basic pharmacokinetics year: 2012 ident: e_1_2_7_23_1 – ident: e_1_2_7_20_1 doi: 10.1111/j.1365-2761.1987.tb01057.x – ident: e_1_2_7_13_1 doi: 10.1016/j.aquaculture.2018.08.023 – ident: e_1_2_7_12_1 doi: 10.1016/j.aquaculture.2018.04.037 – volume-title: AVMA guidelines for the humane slaughter of animals year: 2016 ident: e_1_2_7_25_1 – volume: 7 start-page: 126 year: 2015 ident: e_1_2_7_29_1 article-title: Comparative pharmacokinetics of florfenicol in Japanese eels at different temperature publication-title: Animal Husbandry and Feed Science – ident: e_1_2_7_10_1 doi: 10.1046/j.1365-2656.1999.00337.x – ident: e_1_2_7_14_1 doi: 10.1089/mdr.2008.0848 |
SSID | ssj0017516 |
Score | 2.3648973 |
Snippet | Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug‐related side effects. The current study established a... Optimized dosing regimen is key to the effective use of antibacterials and to minimizing drug-related side effects. The current study established a... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1181 |
SubjectTerms | adverse effects antibiotic resistance Antibiotics Antiinfectives and antibacterials blood proteins Dosage dose response Drug dosages Drugs Fish Florfenicol Freshwater fishes In vivo methods and tests in vivo studies Linearity Marine fishes Metabolism Minimum inhibitory concentration Nile tilapia optimal dosing regimen Oral administration Oreochromis niloticus Pathogens Pharmacodynamics Pharmacokinetics pharmacokinetic–pharmacodynamic Pharmacology Ponds protein binding Saturation Serum Side effects Temperature Temperature dependence Tilapia Water temperature |
Title | Pharmacokinetic–pharmacodynamic modelling for the determination of optimal dosing regimen of florfenicol in Nile tilapia (Oreochromis niloticus) at different water temperatures and antimicrobial susceptibility levels |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjfd.13040 https://www.ncbi.nlm.nih.gov/pubmed/31157416 https://www.proquest.com/docview/2255985676 https://www.proquest.com/docview/2234484542 https://www.proquest.com/docview/2327997296 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VPcGB9yNQ0IA4lIMr4117Y3GqgKiqREGISj0gWfssUVNvZTtCcOI_8O848kuYWT9EeQlxiBTFk8w4_nb3W3vmG8YeSeskMgWeWGFNIqwqEsVJyFUbj_TISRXbt708KPYOxf5RfrTBno61ML0-xHTDjUZGnK9pgCvd_jjIvaVWxoL265SrRYTozSQdhatibHsa0xellPmgKhSzeMZvnl-LfiGY5_lqXHAWl9m7MdQ-z-RkZ93pHfPpJxXH_zyXK-zSQERht0fOVbbh6mvs4u5xM4hxuOvs6-tB1_oEHaDZt89fzoZPbN_IHmIjHapoByS_gGQS7JhfQ1ccgoeAk9IperKBbksAdYI4dfGIX4XGu5qwCMsaDjB06JZUXqdg-1XjgnnfBMQh1MtVIJGQ9jGoDsaeLh18QKKMXh1S_14augVVW3yhx2VUmEK_7bqNqTsxC_gjrChLqr3BDhcv3j7bS4ZeEInh8yJNSMZeZN7wTKdzjXDy1mZFyYWW2huJrEbpeeaV9whKr1PFhbe58GmuSqN0ym-yzTrU7jaDTOtSC9ypUU1wkSlVCDcXT7RRuTCK6xnbHlFRmUEonfp1rKppw-RtFS_XjD2cTM96dZDfGW2N0KqGCaKtsqiMnxeymLEH02H8S-l5japdWJMNx80zRpr9xYZnkmqfS_ydWz1sp0iikBISbjyhCL4_h1jtL57HN3f-3fQuu4DkseyTIbfYZtes3T0kaJ2-H0fidwx2Py4 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VcgAOvB-BAgsCqRxcmfXaTg4cKkKUvgJCrdSbu8_WamJXtqMqnPgP_A3-Cn-AI7-EmfVDlJe49MAhkhWPvLPjmd2Z9cw3hDyLtYnBUwg8zbXyuBaRJwIEcpXKgntkYuHat-1MovEe39wP95fI57YWpsaH6A7c0DLceo0GjgfSP1q51djLmPtNSuWWWZxCwFa-2hjC233O2OjN7uux1_QU8FTQj3wP4dA5sypg0u9LYMtqzaJBwGUsrYphdxSyz6ywFiZnpS8CbnXIrR-KgRLSD-C5F8hF7CCOSP3D9x1YFezDrtGqS5iM4zhscIxc3lDL6tnd7xeX9qyH7La40TXypRVOndlyvDav5Jr68BNu5P8ivevkauNr0_XaOG6QJZPdJFfWD4sGb8TcIl_fNdDdxzAjIPv28dNJ849eZGKWKup6BWHRPgX_noK_THWbQoRKTXNLc1h3ZzCSzvHkhWKzi5lxd-w0L6zJ0NxomtEJyIpWKVYQCrr6tjC5OipyMDWapdMccVDKF1RUtG1bU9FTiAVgVAPRTY1-XVKRafjBiKkD0YJxy3npspNcovOCTjERrLxN9s5FuHfIcpZn5h6hTMqB5BCMYtlzxISIuOnzl1KJkCsRyB5ZbdUwUQ0WPLYkmSZdTGh14tSjR552pCc1AMrviFZaXU6aNbBMmAP_D6M46pEn3W0QKX6SEpnJ50gTcN4HTtlfaAIWY3n3AJ5zt7aTjhOHFQUxBUzIafufWUw2R0N3cf_fSR-TS-Pdne1ke2Oy9YBcBl95UOd-rpDlqpibh-CPVvKRWwYoOThvy_kOb6igJQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKkRAceD8WChgEUjmkCrYTJwcOFcuqD1gqRKXeUj8h6m6y2mRVLSf-Az-Dv8Iv4MgvYew8RHmJSw8cIkXJKB5PZuyZZOYbhB5xbTh4CjTQTKuAaREHgjogV6ksuEeGC9--7dU43tpnOwfRwQr63NXCNPgQ_Qc3Zxl-vXYGPtP2RyO32rUyZmGbUblrlscQr1XPtofwch8TMnrx9vlW0LYUCBRN4jBwaOiMWEWJDBMJXFmtSZxSJrm0isPmKGRCrLAW5mZlKCizOmI2jESqhAwpPPcMOsviMHV9IoZveqwq2IZ9n1WfL8k5j1oYI5821LF6cvP7xaM96SD7HW50CX3pZNMkthxtLGq5oT78BBv5nwjvMrrYetp4szGNK2jFFFfRhc138xZtxFxDX_da4O4jmBCQffv4adZe0ctCTHOFfacgV7KPwbvH4C1j3SUQOZXGpcUlrLpTGEmX7rsLdq0upsbfsZNybk3hjA3nBR6DqHCdu_pBgddfz02p3s9LMDRc5JPSoaBUT7Cocde0psbHEAnAqAZimwb7usKi0HDAiLmH0IJxq0Xlc5N8mvMST1waWHUd7Z-KcG-g1aIszC2EiZSpZBCKuqLnmAgRM5Owp1KJiClB5QCtd1qYqRYJ3jUkmWR9RGh15tVjgB72pLMG_uR3RGudKmftClhlxEP_RzGPB-hBfxtE6n5IicKUC0dDGUuAU_IXGkq4K-5O4Tk3GzPpOfFIURBRwIS8sv-ZxWxnNPQnt_-d9D46tzccZS-3x7t30HlwlNMm8XMNrdbzhbkLzmgt7_lFAKPD0zac7wJfntQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetic-pharmacodynamic+modelling+for+the+determination+of+optimal+dosing+regimen+of+florfenicol+in+Nile+tilapia+%28Oreochromis+niloticus%29+at+different+water+temperatures+and+antimicrobial+susceptibility+levels&rft.jtitle=Journal+of+fish+diseases&rft.au=Rairat%2C+Tirawat&rft.au=Hsieh%2C+Chia-Yu&rft.au=Thongpiam%2C+Wipavee&rft.au=Chou%2C+Chi-Chung&rft.date=2019-08-01&rft.eissn=1365-2761&rft_id=info:doi/10.1111%2Fjfd.13040&rft_id=info%3Apmid%2F31157416&rft.externalDocID=31157416 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0140-7775&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0140-7775&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0140-7775&client=summon |